![[Op-ed] COVID-19 Vaccines and Corporate Brands episode artwork](https://d3t3ozftmdmh3i.cloudfront.net/production/podcast_uploaded_nologo400/11647513/11647513-1644506356799-e56d46992f316.jpg)
EPISODE · Jan 9, 2021 · 7 MIN
[Op-ed] COVID-19 Vaccines and Corporate Brands
from Microdosing · host Paul Schrimpf
It's been rare that anyone has ever known the manufacturer of the vaccines they receive. Yet, as the COVID-19 vaccines come to market, the corporate brands of those vaccines are filling the headlines. In this episode, we explore how that impacts decision-making of doctors and patients as it relates to drug and vaccine selection the future.
Embed this episode
NOW PLAYING
[Op-ed] COVID-19 Vaccines and Corporate Brands
0:00
7:22
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of Microdosing?
This episode is 7 minutes long.
When was this Microdosing episode published?
This episode was published on January 9, 2021.
Can I download this Microdosing episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!